HIKMA FARMACEUTICA FDA Approval ANDA 065046

ANDA 065046

HIKMA FARMACEUTICA

FDA Drug Application

Application #065046

Application Sponsors

ANDA 065046HIKMA FARMACEUTICA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 7.5GM BASE/VIAL0CEFUROXIME SODIUMCEFUROXIME SODIUM

FDA Submissions

ORIG1AP2004-01-09
LABELING; LabelingSUPPL3AP2008-08-25
LABELING; LabelingSUPPL9AP2016-05-06STANDARD
LABELING; LabelingSUPPL11AP2019-11-16STANDARD
LABELING; LabelingSUPPL12AP2021-07-07STANDARD
LABELING; LabelingSUPPL13AP2021-07-07STANDARD

Submissions Property Types

SUPPL9Null15
SUPPL11Null31
SUPPL12Null15
SUPPL13Null15

TE Codes

001PrescriptionAP

CDER Filings

HIKMA FARMACEUTICA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65046
            [companyName] => HIKMA FARMACEUTICA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFUROXIME SODIUM","activeIngredients":"CEFUROXIME SODIUM","strength":"EQ 7.5GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CEFUROXIME SODIUM","submission":"CEFUROXIME SODIUM","actionType":"EQ 7.5GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.